Brain Imaging in the Diabetes Prevention Program Outcomes Study
Status:
Enrolling by invitation
Trial end date:
2022-01-31
Target enrollment:
Participant gender:
Summary
This is a cross-sectional pilot study of Alzheimer's disease (AD) brain imaging biomarkers in
Diabetes Prevention Program (DPP) outcomes study (DPPOS) participants from the New York City
sites (Columbia and Einstein), comparing 10 persons originally randomized to metformin and 10
persons randomized to placebo in DPP. All study procedures will be conducted at Columbia
University Irving Medical Center. Eligible participants will receive a PET scans and a brain
MRI, which may be conducted in one, two, or three separate visits.
Albert Einstein College of Medicine Albert Einstein College of Medicine, Inc. George Washington University National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)